Treatment of Speech Development Disorders in Preschool Children

Objectives. To study the efficacy of Neuroferon in general speech development disorders (SDD). Materials and methods. A total of 30 children of preschool age with SDD were studied; patients were divided into three age groups: 4–5 years (eight patients), 5–6 years (10 patients), and 6–7 years (12 patients). Treatment continued for two months: Neuroferon was given at a dose of one tablet three times a day. Multifaceted psychological investigations of speech disorders were performed using a number of methods. These data were evaluated with consideration of overall mental state and the children’s emotional and behavioral characteristics. Results and conclusions. Neuroferon was found to have therapeutic actions in SDD in children (increases in the level of audioverbal memory, improvements in expressive speech, phonematic perception, and articular motor function, and increases in vocabulary and the production of connected speech, etc.), which were accompanied by decreases in anxiety, hyperactivity, and attention deficit. Use of Neuroferon was shown to be safe for children. The authors regard these results as preliminary. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.